GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Intelligent Bio Solutions Inc (FRA:12Q0) » Definitions » Cash, Cash Equivalents, Marketable Securities

Intelligent Bio Solutions (FRA:12Q0) Cash, Cash Equivalents, Marketable Securities : €8.65 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Bio Solutions Cash, Cash Equivalents, Marketable Securities?

Intelligent Bio Solutions's quarterly cash, cash equivalents, marketable securities increased from Sep. 2023 (€0.17 Mil) to Dec. 2023 (€1.03 Mil) and increased from Dec. 2023 (€1.03 Mil) to Mar. 2024 (€8.65 Mil).

Intelligent Bio Solutions's annual cash, cash equivalents, marketable securities declined from Jun. 2021 (€10.44 Mil) to Jun. 2022 (€7.79 Mil) and declined from Jun. 2022 (€7.79 Mil) to Jun. 2023 (€1.42 Mil).


Intelligent Bio Solutions Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Intelligent Bio Solutions's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Bio Solutions Cash, Cash Equivalents, Marketable Securities Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 0.18 0.38 10.44 7.79 1.42

Intelligent Bio Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 1.42 0.17 1.03 8.65

Intelligent Bio Solutions Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Intelligent Bio Solutions  (FRA:12Q0) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Intelligent Bio Solutions Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Intelligent Bio Solutions's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelligent Bio Solutions Business Description

Traded in Other Exchanges
Address
57th Street, 142 West, 11th Floor, New York, NY, USA, 10019
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana.

Intelligent Bio Solutions Headlines

No Headlines